These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32060223)

  • 1. Environmental and Personnel Monitoring Programs-A Risk-Based Case Study of
    Tidswel EC; Boone K
    PDA J Pharm Sci Technol; 2020; 74(4):408-422. PubMed ID: 32060223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies.
    Dalmaso G; Campanella A; Lazzeri P
    PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study.
    Ziegler I; Borbély-Jakab J; Sugó L; Kovács RJ
    PDA J Pharm Sci Technol; 2017; 71(3):234-244. PubMed ID: 28089966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different incubation conditions for microbiological environmental monitoring.
    Gordon O; Berchtold M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
    Eissa ME
    PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contamination Control.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products.
    Parveen S; Kaur S; David SA; Kenney JL; McCormick WM; Gupta RK
    Vaccine; 2011 Oct; 29(45):8012-23. PubMed ID: 21871516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous microbiological air monitoring for aseptic filling lines.
    Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F
    PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charting and Evaluation of Environmental Microbial Monitoring Data.
    Bar R
    PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Elkins JM; Dennis DA; Kleeman-Forsthuber L; Yang CC; Miner TM; Jennings JM
    Bone Joint J; 2020 Jul; 102-B(7_Supple_B):52-56. PubMed ID: 32600208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Recovery Rate of Different Swabs for Microbial Environmental Monitoring.
    Goverde M; Willrodt J; Staerk A
    PDA J Pharm Sci Technol; 2017 1/2; 71(1):33-42. PubMed ID: 27516491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of rapid microbiological methods for the risk assessment of controlled biopharmaceutical environments.
    Sandle T; Leavy C; Jindal H; Rhodes R
    J Appl Microbiol; 2014 Jun; 116(6):1495-505. PubMed ID: 24575809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutibacterium acnes Isolates from Deep Tissue Specimens Retrieved during Revision Shoulder Arthroplasty: Similar Colony Morphology Does Not Indicate Clonality.
    Bumgarner RE; Harrison D; Hsu JE
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31645372
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary investigation into the ability of three rapid microbiological methods to detect microorganisms in hospital intravenous pharmaceuticals.
    Hiom S; Denyer S; Talbot C; Maillard JY; Spark P; Smith J
    PDA J Pharm Sci Technol; 2013; 67(4):376-86. PubMed ID: 23872446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.